1050: Tranexamic Acid Might Need to be Given Sooner Than Once Thought to Help Trauma Patients
Show notes at pharmacyjoe.com/episode1050. In this episode, I’ll discuss tranexamic acid’s effects on mortality for trauma patients based on time…
FDA Moves to Restrict 7-OH Opioid Products
The FDA targets 7-hydroxymitragynine, a potent kratom derivative, as a controlled substance due to its opioid-like effects and rising health…
Focusing on Cardiovascular Health in Childhood Shows Lifelong Benefits
Promoting heart health in children reduces obesity and chronic disease risks, ensuring better overall well-being into adulthood.
From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations
Amid dropping vaccination rates, pharmacists are key to educating parents and assuaging concerns.
Caffeine vs. Guarana: Can AI Predict Which Stimulant Packs the Bigger Punch?
AI-driven analysis reveals guarana offers more sustained cognitive stimulation than caffeine, due to additional bioactive compounds and slower caffeine release…
LDL-C–Lowering Inclisiran May Carry Lower Risk of Diabetes Than Atorvastatin
Inclisiran was found to have a lower risk causing new-onset diabetes compared with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies.
Study Finds Association Between Lung Cancers and Ultra-Processed Foods
Recent data link a higher consumption of ultra-processed food to increased lung cancer risk, highlighting the need for dietary changes…
Can Cilta-Cel Redefine Outcomes in Multiple Myeloma?
CARTITUDE-1 data show one-third of patients treated with cilta-cel remain progression-free at 5 years without maintenance.
Pharmacy Orgs Urge Court to Uphold Tennessee’s Right to Regulate PBMs
Without regulation, PBMs have engaged in abusive practices, say pharmacy groups.
Multiple Myeloma: A Modern Look at an Ancient Disease and 2025’s Therapeutic Breakthroughs
Discover the latest advancements in multiple myeloma treatment, including new therapies and FDA approvals that enhance patient outcomes and survival…